At #ESMO26, Randy Sweis, MD, presents interim results from cohort 7 of the phase 1b TROPHY-U-01 trial, testing SG + EV + zimberelimab as first-line treatment for metastatic urothel

UChicago Medicine Comprehensive Cancer Center· @UCCancerCenter · X·2026-10-23 23:22· 2 days agoScore45

Body

At #ESMO26, Randy Sweis, MD, presents interim results from cohort 7 of the phase 1b TROPHY-U-01 trial, testing SG + EV + zimberelimab as first-line treatment for metastatic urothelial cancer. #bladdercancer @RandySweis

376 views · 10 likes · 5 reposts · 0 replies

Conference abstracts

4742Omatched by Proffered paper 1: Genitourinary tumour, renal and urothelial

Sacituzumab Govitecan (SG) Combined With Enfortumab Vedotin (EV) and Zimberelimab (ZIM) in Treatment-Naive Metastatic Urothelial Cancer (mUC): Interim Results From Phase 1b TROPHY-U-01 Cohort 7

https://esmocongress.esmo.org

Source: UChicago Medicine Comprehensive Cancer Center · x.com